REDucing Unnecessary Coagulation Testing in the Emergency Department (REDUCED)
Michael Fralick1, Lisa K Hicks1, Hina Chaudhry1
1Department of Medicine, Department of Laboratory Medicine and Pathobiology, Department of Emergency Medicine, Division of Hematology/Oncology, Li Ka Shing Knowledge Institute St. Michael's Hospital, Toronto, Ontario, Canada.
Insights
Routine coagulation testing, including prothrombin time/international normalized ratio (PT/INR) and activated partial thromboplastin time (aPTT), was significantly reduced in the emergency department through a quality improvement initiative. A simple order panel revision led to decreased PT/INR and aPTT testing without adverse effects.
Area of Science:
- Clinical Pathology
- Healthcare Quality Improvement
- Emergency Medicine
Background:
- Prothrombin time/international normalized ratio (PT/INR) and activated partial thromboplastin time (aPTT) are historically significant coagulation tests.
- These tests are frequently ordered together in emergency departments despite unique indications.
- Overutilization of coagulation testing can lead to increased healthcare costs and potential patient harm.
Purpose of the Study:
- To evaluate the effectiveness of a multimodal intervention in reducing routine PT/INR and aPTT testing in the emergency department.
- To assess the impact of changes in order panels on coagulation test utilization.
- To determine if reducing these tests impacts patient care or other laboratory test ordering.
Main Methods:
- A prospective, multi-pronged quality improvement study was conducted at St. Michael's Hospital.
- Interventions included stakeholder engagement, decoupling of PT/INR and aPTT orders, educational initiatives, and crucially, a revision of electronic order panels.
- Weekly testing rates per 100 emergency department patients were tracked, with creatinine testing used as an internal control.
Main Results:
- Following the order panel revision, weekly PT/INR testing decreased from 38.4 to 17.2 per 100 ED patients (rate ratio=0.45, p<0.001).
- Weekly aPTT testing decreased from 37.8 to 16.6 per 100 ED patients (rate ratio=0.44, p<0.001).
- Creatinine testing rates increased (rate ratio=1.09, p<0.0001), and blood transfusion rates slightly decreased (rate ratio=0.66, p=0.0034), indicating no widespread negative impact.
Conclusions:
- A straightforward process change, specifically modifying order panels, can significantly reduce unnecessary coagulation testing in the emergency department.
- This intervention achieved meaningful reductions in PT/INR and aPTT utilization without apparent adverse clinical consequences.
- Optimizing laboratory test ordering through quality improvement initiatives is feasible and beneficial for healthcare resource management.
Abstract:
The PT/INR (prothrombin time/international normalized ratio) and aPTT (activated partial thromboplastin time) were tests developed in the early 20th century for specific and unique indications. Despite this, they are often ordered together routinely. The objective of this study was to determine if a multimodal intervention could reduce PT/INR and aPTT testing in the emergency department (ED). This was a prospective multi-pronged quality improvement study at St. Michael's Hospital. The initiative involved stakeholder engagement, uncoupling of PT/INR and aPTT testing, teaching, and most importantly a revision to the ED order panels. After changes to order panels, weekly rates of PT/INR and aPTT testing per 100 ED patients decreased (17.2 vs 38.4, rate ratio=0.45 (95% CI 0.43-0.47), p<0.001; 16.6 vs 37.8, rate ratio=0.44 (95% CI 0.42-0.46), p<0.001, respectively). Rate of creatinine testing per 100 ED patients, our internal control, increased during the same period (54.0 vs 49.7, rate ratio=1.09 (95% CI 1.06-1.12); p<0.0001) while the weekly rate per 100 ED patients receiving blood transfusions slightly decreased (0.5 vs 0.7, rate ratio=0.66 (95% CI 0.49-0.87), p=0.0034). We found that a simple process change to order panels was associated with meaningful reductions in coagulation testing without obvious adverse effects.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis IV: Nursing Management


